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Activation of the SOS response increases 
the frequency of small colony variants
Martin Vestergaard, Wilhelm Paulander and Hanne Ingmer*
Abstract 
Background: In Staphylococcus aureus sub-populations of slow-growing cells forming small colony variants (SCVs) 
are associated with persistent and recurrent infections that are difficult to eradicate with antibiotic therapies. In SCVs 
that are resistant towards aminoglycosides, mutations have been identified in genes encoding components of the 
respiratory chain. Given the high frequencies of SCVs isolated clinically it is vital to understand the conditions that 
promote or select for SCVs.
Results: In this study we have examined how exposure to sub-inhibitory concentrations of antibiotics with differ-
ent mechanism of action influence the formation of SCVs that are resistant to otherwise lethal concentrations of the 
aminoglycoside, gentamicin. We found that exposure of S. aureus to fluoroquinolones and mitomycin C increased the 
frequency of gentamicin resistant SCVs, while other antibiotic classes failed to do so. The higher proportion of SCVs in 
cultures exposed to fluoroquinolones and mitomycin C compared to un-exposed cultures correlate with an increased 
mutation rate monitored by rifampicin resistance and followed induction of the SOS DNA damage response.
Conclusion: Our observations suggest that environmental stimuli, including antimicrobials that reduce replication 
fidelity, increase the formation of SCVs through activation of the SOS response and thereby potentially promote per-
sistent infections that are difficult to treat.
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Background
The formation of a small colony phenotype compared 
to wild type colony morphology has been observed in 
clinical specimens across many bacterial genera com-
prising Gram-positives and -negatives [1]. Clinically, 
the emergence of slow-growing Staphylococcus aureus 
mutants, known as small colony variants (SCVs), is asso-
ciated with sub-acute infections displaying enhanced 
intracellular residency in host cells promoting persistent 
and recurrent infections and an increased risk of anti-
biotic treatment failure [1]. The SCV phenotype can be 
caused by disruptions of metabolic pathways, conferred 
either by mutations in the gene thyA of the pathway that 
converts uracil to thymidine [2] or by mutations in the 
menadione and hemin production pathways resulting in 
a dysfunctional electron transport chain [3, 4]. Depend-
ing on the pathways inactivated, antibiotic resistance to 
different classes of antimicrobial agents may occur [5]. 
Mutations in thyA confer trimethoprim-sulfamethoxa-
zole resistance [2, 6], while mutations in genes of the bio-
synthesis pathways encoding menadione or hemin confer 
resistance to aminoglycosides [3, 4] and certain anti-
microbial peptides [7, 8]. The resistance mechanism to 
aminoglycosides in SCVs defective in the electron trans-
port chain has been linked to a decrease in membrane 
potential compared to wild type cells, causing a reduc-
tion in aminoglycosides uptake [1, 9]. SCVs with a defec-
tive electron transport chain exhibit distinct phenotypic 
characteristics affecting pathogenesis, i.e. reduced pig-
mentation, decreased hemolysis activity and most often 
display auxotrophy for menadione and hemin [1]. In a 
wild type S. aureus population a sub-population exists as 
SCVs [10], however environmental stimuli may increase 
the frequency of SCV formation. Increased frequency of 
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S. aureus gentamicin resistant SCVs has been detected 
during co-cultures of S. aureus and Pseudomonas aerugi-
nosa [11], in the intracellular milieu of endothelial cells 
[12] or in strains with reduced replication fidelity [13]. 
Short-term enhanced mutation rates of bacterial cells can 
occur through activation of the SOS response [14] and 
therefore activation of the SOS response could poten-
tially increase the frequency of SCVs. The SOS regulon 
is generally repressed by LexA, but upon DNA damage 
it undergoes autocleavage in response to RecA binding 
to single-stranded DNA [15]. Inactivation of the LexA 
repressor leads to the expression of the SOS regulon. This 
regulon includes genes involved in DNA repair, recom-
bination, as well as error-prone polymerases [16]. The 
error-prone polymerase V, encoded by the gene umuC, 
is highly up-regulated upon SOS response activation in 
S. aureus [17, 18]. In addition to traditional DNA dam-
aging agents like UV and mitomycin C, other agents also 
induce the SOS response such as antibiotics of the flou-
roquinolone class, i.e. ciprofloxacin and moxifloxacin [17, 
18]. Therefore we have investigated if antimicrobial com-
pounds that interfere with DNA-, RNA-, protein- and 
cell wall synthesis affect the proportion of SCVs in the 
population.
Results and discussion
To address the effect of the SOS response and exposure 
to antimicrobials on the formation of gentamicin resist-
ant SCVs in S. aureus we employed two strains, the wild 
type strain 8325-4 as well as an isogenic mutant express-
ing a non-cleavable LexA variant (lexA S130A) that is 
unable to induce the SOS response [18]. When meas-
uring the minimum inhibitory concentration (MIC) of 
the strains, increased susceptibility was evident for the 
lexA(S130A) mutant towards chloramphenicol, as well as 
the DNA targeting antimicrobials; ciprofloxacin, moxi-
floxacin and mitomycin C, while equal MIC between the 
two strains was observed for gentamicin, rifampicin and 
vancomycin (Table 1).
Subsequently we measured the effect of sub-inhibitory 
concentrations (0.5 MIC) of antibiotics on the forma-
tion of gentamicin resistant SCVs using the wild type 
S. aureus strain 8235-4 and the isogenic lexA(S130A) 
mutant. The frequency of gentamicin resistant SCVs in an 
un-exposed culture of 8325-4 was on average 5.1 × 10−7, 
whereas 24 h exposure to mitomycin C, ciprofloxacin and 
moxifloxacin increased the frequencies of SCVs 11-, 15- 
and 8-fold, respectively, compared to the SCV frequency 
of the un-exposed 8325-4 (Fig.  1). The remaining three 
antimicrobials assayed, chloramphenicol, vancomycin 
and rifampicin, did not affect SCV formation. For the 
mutant strain expressing the non-cleavable lexA(S130A) 
exposure to none of the antimicrobials influenced SCV 
formation (Fig. 1). These results suggest that antimicro-
bials targeting DNA enhance SCV formation in an SOS 
dependent manner.
The increased frequency of SCVs observed in response 
to compounds causing DNA damage led us to investi-
gate if the SOS regulon was activated. Activation of the 
SOS regulon was monitored with a recA::lacZ fusion in 
8325-4. Expression of the recA gene was induced when 
exposed to mitomycin C, ciprofloxacin and moxifloxa-
cin, while none of the remaining three agents increased 
the expression of recA (Fig.  2). The SOS regulon con-
trols the expression of the error-prone polymerase Pol 
V, which confers increased mutation frequency in S. 
aureus [18]. Reduced replication fidelity could account 
for the increased number of SCV observed for the agents 
Table 1 MICs (μg/ml) of  the antimicrobials used in  this 
study for 8325-4 and its lexA derivative
Antibiotic 8325-4 lexA(S130A)
Gentamicin 1 1
Ciprofloxacin 1/2 1/4
Moxifloxacin 1/16 1/32
Vancomycin 1 1
Chloramphenicol 4 2
Rifampicin 1/512 1/512
Mitomycin C 1/8 1/32
Fig. 1 Effect of sub-inhibitory concentrations of antimicrobials on 
SCV frequency. The frequency of gentamicin resistant SCVs in WT 
8325-4 (black) population and in the isogenic mutant lexA(S130A) 
(white) grown in absence of antibiotics (NO AB) or in the presence of 
sub-inhibitory concentrations of CIP (Ciprofloxacin), MXF (Moxifloxa-
cin), MMC (Mitomycin C), VAN (Vancomycin), RIF (Rifampicin) and 
CAM (Chloramphenicol). Concentrations of antimicrobials are 0.5 
MIC of the respective strains. The bars represent the mean from 8 
independent selections of each condition and error bars represent 
95 % confidence intervals
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activating the SOS regulon. Mutation frequency has pre-
viously been monitored by rifampicin resistance, which 
arises by point mutations in rpoB [19]. The frequency of 
rifampicin resistant mutants in un-exposed cultures of 
the two strains was similar and approximately 3 × 10−8. 
In contrast exposure of 8325-4 to mitomycin C, cipro-
floxacin and moxifloxacin increased the frequency of 
rifampicin resistant mutants 10-, 8- and sixfold respec-
tively, whereas none of the remaining antibiotics for 
8325-4 or any of the antibiotics for the lexA(S130A) 
mutant strain affected the frequency of rifampicin resist-
ance (Fig.  3). Several of the antibiotics (ciprofloxacin, 
chloramphenicol and rifampicin) at the tested concentra-
tion also significantly reduced growth rates in exponen-
tial phase, yet no correlation between growth rate and 
increased frequency of SCVs was observed (Fig. 4).  
Strains displaying higher basal mutation rates have 
been detected in several clinical SCV isolates with auxo-
trophies for hemin [13] and thymidine [20]. Identification 
of hypermutators among clinical SCV isolates suggests 
that high mutations rates may contribute to the emer-
gence and establishment of SCV infections [13, 20]. Not 
only exposure to sub-inhibitory concentrations of anti-
biotics that trigger activation of the SOS response and 
a temporary increase in mutation rate may facilitate the 
emergence of SCVs, but also conditions following contact 
with the immune system may activate the SOS response 
[21]. As part of the host defense mechanism against 
infections, neutrophils generate reactive oxygen species, 
such as hydrogen peroxide and superoxide [22] that can 
damage DNA and trigger expression of the SOS regulon 
[21]. It has recently been shown that exposure to sub-
inhibitory concentrations of hydrogen peroxide indeed 
increases the frequency of gentamicin resistant SCVs via 
activation of the SOS response [23]. Therefore chemical 
Fig. 2 Sub-inhibitory concentrations of DNA-damaging agents 
activate the SOS-response. Activation of the SOS-response was 
monitored as β-galactosidase activity from a recA::lacZ fusion in strain 
8325-4, when grown in absence (NO AB) or in the presence of sub-
inhibitory concentrations of CIP (Ciprofloxacin), MXF (Moxifloxacin), 
MMC (Mitomycin C), VAN (Vancomycin), RIF (Rifampicin) and CAM 
(Chloramphenicol). The bars represent the mean from 3 independ-
ent experiments of each condition and error bars represent 95 % 
confidence intervals
Fig. 3 Effect of sub-inhibitory concentrations of antimicrobials 
on the frequency of rifampicin resistant mutants. The frequency of 
rifampicin resistant mutants in WT 8325-4 (black) population and in 
the isogenic mutant lexA(S130A) (white) grown in absence of antibiot-
ics (NO AB) or in the presence of sub-inhibitory concentrations of CIP 
(Ciprofloxacin), MXF (Moxifloxacin), MMC (Mitomycin C), VAN (Van-
comycin), RIF (Rifampicin) and CAM (Chloramphenicol). Concentra-
tions of antimicrobials are 0.5 MIC of the respective strains. The bars 
represent the mean from 8 independent selections of each condition 
and error bars represent 95 % confidence intervals
Fig. 4 Sub-inhibitory concentrations of antimicrobials on the 
growth rate of strain 8325-4. The growth rate of strain 8325-4 
grown in absence (NO AB) is set to 1 and the relative growth rates 
are presented of 8325-4 when grown in the presence of sub-
inhibitory concentrations of CIP (Ciprofloxacin), MXF (Moxifloxacin), 
MMC (Mitomycin C), VAN (Vancomycin), RIF (Rifampicin) and CAM 
(Chloramphenicol). The bars represent the mean from 3 independ-
ent experiments of each condition and error bars represent 95 % 
confidence intervals
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inhibition that prevents activation of the SOS response 
could potentially be used as adjuvants to reduce the 
emergence and establishment of SCVs during infection, 
a strategy that has also been proposed to decelerate the 
evolution of antibiotic resistance towards various antimi-
crobial classes [24, 25].
Conclusion
In conclusion, our data suggests that environmental stim-
uli that elevate the mutation rate of S. aureus, i.e. through 
activation of the SOS response, stimulate the emergence 
of SCVs that are associated with persistent S. aureus 
infections. Caution should be taken when treating S. 
aureus empirically with broad-spectrum antibiotics such 
as fluoroquinolones when lacking resistance data, since 
sub-inhibitory exposure could increase the proportion of 
SCV and thereby limit further treatment options.
Methods
Bacterial strains, growth conditions and MIC
The strains used in this study include the S. aureus strains 
8325-4, 8325 lexA(S130A)::SpecR [18] and HI2682, a 8325-4 
strain containing a recA::lacZ fusion [26]. Strains were 
grown at 37 °C in tryptic soy broth (TSB) or on tryptic soy 
agar (TSA) plates with or without gentamicin (Sigma), cip-
rofloxacin (Sigma), moxifloxacin (Sigma), chlorampheni-
col (Sigma), vancomycin (Sigma), rifampicin (Sigma) and 
mitomycin C (Sigma). The minimum inhibitory concentra-
tions (MIC) were determined by broth micro-dilution assay 
according to CLSI guidelines, except that cation-adjusted 
Mueller–Hinton broth was substituted with TSB.
Quantification of small colony variants and rifampicin 
resistant mutants
Over night (ON) cultures of 8325-4 and 8325 
lexA(S130A)::SpecR were diluted 1000-fold in 1  ml TSB 
in a 10  ml falcon tube, supplemented with or without 
0.5 MIC of the antimicrobials assayed. The cultures were 
grown for 24  h at 37  °C with shaking (200  rpm). Total 
colony forming units (CFU) were determined on TSA 
plates, the number of gentamicin resistant small colony 
variants were estimated on TSA supplemented with gen-
tamicin (4  μg/ml) and rifampicin resistant mutant CFU 
were determined on TSA supplemented with rifampicin 
(5 μg/ml). Plates were incubated at 37 °C. Total CFU and 
rifampicin resistant mutants were counted following 24 h 
growth and SCVs were counted after 48 h growth. SCVs 
were defined as colonies resistant to gentamicin (>4 μg/
ml) that displayed slow growth and significantly smaller 
colony morphology (approximately tenfold) compared 
to WT strain 8325-4. The frequency of SCV was deter-
mined as the number of SCV divided by the total CFU 
count. The same procedure was used in the calculation of 
rifampicin mutation frequency. The frequencies reported 
are a mean of 8 independent experiments.
β-galactosidase assay with recA::lacZ fusion
β-galactosidase activity was measured from strain 
HI2682, a 8325-4 strain with recA::lacZ fusion. Cells 
were grown in 10 ml TSB in 100 ml Erlenmeyer flasks at 
37 °C with shaking with and without the presence of sub-
inhibitory concentrations (0.5 MIC) of antimicrobials to 
an OD600 of 0.5. The assay was performed as described by 
Sambrook and Russell [27]. The reported β-galactosidase 
activities are a mean of three independent experiments.
Fitness measurement
The fitness of cells exposed to sub-inhibitory concentra-
tions of antimicrobials was estimated by growth rate (µ) 
comparisons in exponential phase. Growth rates were 
determined for cells inoculated at 106 cells/ml and grown 
with or without antibiotics at a concentration of 0.5 MIC 
at 37  °C in a Bioscreen C (Oy Growth Curves Ab Ltd) 
with OD600 measurements at 5 min intervals. The relative 
fitness was calculated as: µ(mutant)/µ(WT).
Statistics
Significant difference was calculated by 1-way ANOVA, using 
log-transformed datasets  for SCV and rifampicin resistance 
frequency, with a post hoc analysis of Dunnett Multiple Com-
parison Tests (*p < 0.05, **p < 0.01). Statistics were performed 
in GraphPad Prism 4 (GraphPad Software, Inc).
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